← FDA Drug Approvals (Drugs@FDA)

ONPATTRO

NDA · New Drug Application · Sponsor: ALNYLAM PHARMS INC · Approved 2018-08-10

Drug application

FDA Application #

NDA210922

Application type

New Drug Application

Brand name

ONPATTRO

Generic name

PATISIRAN

Active ingredients

PATISIRAN SODIUM

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

ALNYLAM PHARMS INC

Manufacturer

Alnylam Pharmaceuticals, Inc.

First approval

2018-08-10

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown